Press Releases

Date	Latest News	PDF
28-Oct-2024	Eurofins agrees to acquire SYNLAB’s clinical diagnostics operations in Spain
22-Oct-2024	Eurofins confirms profitability and cash flow objectives for 2024 leading to higher profit margins in spite of the impact of the post-COVID reset of BioPharma pipelines
22-Oct-2024	Eurofins announces results of cash audit confirming its FY 2023 cash balance and the high integrity of its systems and controls and refutes Muddy Waters’ allegations regarding transactions that occurred between 10 and 25 years ago
16-Sep-2024	The Eurofins network expands its BioPharma Product Testing offering in the United States with the acquisition of Infinity Laboratories, Inc.
2-Sep-2024	Eurofins launches third buy-back programme of its own shares
23-Aug-2024	The Eurofins network announces availability of Real-time PCR assay for the identification of the mpox virus (formerly monkeypox), as WHO declares mpox a Public Health Emergency of International Concern and Health Authorities recommend increased testing
24-Jul-2024	Eurofins delivers new record level of revenues and strong margins and cash flow growth in H1 2024
15-Jul-2024	Eurofins disputes the validity of SGS’ purported termination of the agreement to divest its crop science operations to Eurofins
11-Jul-2024	Eurofins provides update to key stakeholders on current and upcoming actions following communications published by Muddy Waters since 24 June 2024
5-Jul-2024	Eurofins provides further refutations to another set of baseless allegations and misleading information spread by Muddy Waters
<< < 1 2 > >>